Examples of successful in-licensing:

 

PIRIBEDIL (CLARIUM®)

LICENSED FROM SERVIER (DE)

 

  • Non-ergoline dopamine agonist
  • Indicated for Parkinson's disease (monotherapy, add-on, early and late stage patients)

 

 

RILUZOL (TEGLUTIK®)

LICENSED FROM ITALFARMACO S.A. (DE) 

 

  • Riluzol oral suspension
  • Indicated for amyotrophic lateral sclerosis

 

 

TETRABENAZINE (TETMODIS®)

LICENSED FROM ORPHA TRADE GMBH (DE) 

 

  • Indicated for Huntington's disease

 

 

BOTULINUM TOXIN A (XEOMIN®)

LICENSED FROM MERZ (DK, NO, RO, SK, CZ)

 

  • Registered for the symptomatic treatment of blepharospasm and cervical dystonia of a predominantly rotational form (spasmodic torticollis) and of post-stroke spasticity of the upper limb

 

 

STIRIPENTOL (DIACOMIT®)

LICENSED FROM BIOCODEX (DE, CZ, SK, RO)

 

  • Orphan Drug with EMA approval
  • Indicated for the treatment of severe myoclonic epilepsy (Dravet's Syndrom)

 

 

5-AMINOLEVULINIC ACID (AMELUZ®)

LICENSED FROM BIOFRONTERA (DK, NO, SE)

 

  • EMA approval for the treatment of  actinic keratosis (AK) and certain types of basal cell carcinoma
  • Good efficacy in photodynamic therapy of actinic keratosis (AK)

 

 

 

Country Codes:  Germany (DE), Denmark (DK), Norway (NO), Sweden (SE), Finnland (FI), Czech Republic (CZ), Slovakia (SK), Romania (RO)